Impact of the COVID-19 pandemic on non–small-cell lung cancer pathologic stage and presentation

• DOI: 10.1503/cjs.016721
• Publication Date: 2022-08-04T14:10:30Z
• Authors: Joshua A.J. Keogh; Allison D. Chhor; Housne Begum; Noori Akhtar-Danesh; Christian Finley
• Keywords: Pandemic

<h3>Background:</h3> It is believed that the cessation of normative cancer care services during COVID-19 pandemic may be resulting in pathologic upstaging and higher long-term mortality rates. We aimed to understand how has affected our patients diagnosed with non–small-cell lung (NSCLC). <h3>Methods:</h3> conducted a single-centre retrospective analysis assess patient referrals, stage NSCLC, rates surgical procedures at centre Ontario, Canada. At centre, physicians advocated for followed recommendations operations should among last delayed. Patients were included if they aged 18 years or older, not receiving palliative care, had been screened, treated NSCLC (primary tumours). compared outcomes between prepandemic period (January 2019 February 2020) (March 2020 2021). <h3>Results:</h3> A total 695 statistical analysis, whom 650 underwent surgery. There was no statistically significant difference any interest seen before (<i>n</i> = 330) 320) pandemic. <h3>Conclusion:</h3> Cancer maintained pandemic, potential adverse effects on prognosis survival have other countries avoided. The results inform health providers future pandemics can blunted by using proactive preservative strategies surgeon advocacy.